The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
NCT06218927 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-01-23
Summary
Academic research project monitoring the effect of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) on multiple sclerosis-associated lower urinary tract symptoms.
Conditions
- Multiple Sclerosis
- Lower Urinary Tract Symptoms
Interventions
- OTHER
-
QoL monitoring
QoL questionnaire
Sponsors & Collaborators
-
University Hospital Ostrava
lead OTHER
Principal Investigators
-
Radek Paus Sýkora, MD · University Hospital Ostrava
-
Jan Krhut, prof.,MD,PhD · University Hospital Ostrava
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
NCT03069170 ·Status: UNKNOWN ·Phase: PHASE1
-
Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells
NCT02674217 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
NCT06267781 ·Status: RECRUITING
-
Biomarkers of aHSCT
NCT06195800 ·Status: RECRUITING
-
Autologous Stem Cell Transplant for Multiple Sclerosis
NCT01099930 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis
NCT02035514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Normobaric Hypoxic Training and Multiple Sclerosis
NCT02509897 ·Status: COMPLETED ·Phase: NA
-
Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?
NCT06507800 ·Status: NOT_YET_RECRUITING
-
Neural Stem Cell Transplantation in Multiple Sclerosis Patients
NCT03269071 ·Status: COMPLETED ·Phase: PHASE1
-
Intermittent Hypoxia Intervention in MS Patients
NCT04635033 ·Status: COMPLETED
-
Multiple Sclerosis Self Monitoring Study
NCT06125301 ·Status: RECRUITING ·Phase: NA
-
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
NCT02137044 ·Status: COMPLETED ·Phase: NA
-
Spinal Cord Monitoring in Multiple Sclerosis
NCT06827834 ·Status: RECRUITING
-
A RCT of Telephone-supported ACT in MS
NCT02596633 ·Status: UNKNOWN ·Phase: PHASE3
-
Behavioural Activation for Low Mood in Multiple Sclerosis
NCT03935529 ·Status: COMPLETED ·Phase: NA
-
Acceptance Based Telephone Support When Transitioning to SPMS
NCT04239664 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS
NCT04931953 ·Status: UNKNOWN ·Phase: NA
-
Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis
NCT03113162 ·Status: UNKNOWN ·Phase: PHASE1
-
Self Help for Fatigue in Multiple Sclerosis
NCT01532037 ·Status: COMPLETED ·Phase: NA
-
Coaching and Activity Tracking in Multiple Sclerosis - A Pilot Study
NCT03335618 ·Status: COMPLETED ·Phase: NA
-
Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis
NCT05320237 ·Status: COMPLETED ·Phase: NA
-
Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis
NCT04823000 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Brain Activations and Physiological Responses Using NeuroBiofeedback in Patients With Multiple Sclerosis
NCT06239090 ·Status: RECRUITING ·Phase: NA
-
Sexual Dysfunction in Women With Multiple Sclerosis (MS)
NCT07193823 ·Status: RECRUITING